Skip to main content

stock

INM · InMed Pharmaceuticals Inc.

What InMed Pharmaceuticals Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live INM price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on INM.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
5,493,735 as of 2026-09-02 (XBRL frame CY2026Q3I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
29.7%
Operating
—
Net
—

Returns

ROE
-1168.4%
ROA
-414.5%

Health

Current ratio
1.4x
Debt/equity
—

Deep value

NCAV
$721,646
NCAV per share
$0.13
Price/NCAV
Locked
NNWC
$239,353
NNWC per share
$0.04
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30———-$5.84M
S-4/A filed 2026-09-29
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2026-03-31———-$2.97M
S-4 filed 2026-07-02
2025-12-31$820,188$184,194—-$2.03M
S-4 filed 2026-07-02
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$1.12M$403,159—-$1.73M
S-4 filed 2026-07-02
Assembled from more than one filing; the filing above is only the newest of them.
2025-06-30$1.30M$576,654—-$1.79M
S-4/A filed 2026-09-29
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-03-31$1.26M$175,625—-$2.12M
S-4 filed 2026-07-02
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$1.11M$460,894—-$2.58M
S-4 filed 2026-07-02
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$1.26M$493,413—-$1.68M
S-4 filed 2026-07-02
Assembled from more than one filing; the filing above is only the newest of them.
Assets
$3.03M
Equity
$1.08M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2026-06-30——-$12.56M—
2025-06-30$4.94M—-$8.16M-$8.10M
2024-06-30$4.60M—-$7.68M-$7.00M
2023-06-30$1.37M-$7.95M-$7.95M-$7.44M
2022-06-30$1.37M-$18.60M-$18.60M-$15.62M
2021-06-30$1.90M-$10.20M-$10.20M-$9.79M
2020-06-30——-$8.94M-$7.42M

Company filings

since Fri Mar 20 · 2 offering filings in 12 months · since Fri Apr 3

events

  • Listing standard notice, Other event

    Listing standard noticeOther event
    Sep 188-K
  • Regulation FD disclosure, Other event

    Regulation FD disclosureOther event
    Jul 228-K
  • Material agreement, Regulation FD disclosure

    Material agreementRegulation FD disclosure
    Jul 108-K
  • Other event

    Other event
    Jun 108-K
  • Material agreement, Change in control, Executive or director change, Regulation FD disclosure

    Material agreementChange in controlExecutive or director changeRegulation FD disclosure
    May 198-K
  • Material agreement, Shareholder rights changed, Other event

    Material agreementShareholder rights changedOther event
    May 198-K

5% owners ()

  • Ikarian Capital, LLC

    Passive stake

    4.2%Aug 14SCHEDULE 13G
  • Vivo Opportunity Fund Holdings, L.P.

    Activist stake

    21.7%Jun 10SCHEDULE 13D
  • ADAR1 Capital Management, LLC

    Passive stake

    24.1%Jun 5SCHEDULE 13G
  • Squadron Master Fund LP

    Passive stake

    9.8%May 27SCHEDULE 13G
  • SABBY MANAGEMENT, LLC

    Passive stake

    9.9%Jan 20SCHEDULE 13G

Insiders, politicians and funds

Insider trades, last 90 days

  • ADAR1 Capital Management, LLC

    10% owner

    Buy$57,080

    Oct 5, 5:11 PM ET

  • ADAR1 Capital Management, LLC

    10% owner

    Buy$118,076

    Sep 16, 6:58 PM ET

  • ADAR1 Capital Management, LLC

    10% owner

    Buy$1,555

    Jul 17, 7:29 PM ET

  • Vivo Opportunity, LLC

    10% owner

    Buy$31,846

    Jul 16, 9:58 PM ET

All insider trades for INM

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named INM, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about INM.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about INM.

nakagai

Signals on INM come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the INM board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

InMed Pharmaceuticals Inc. (INM): SEC filings, financials and insider trades · Nakagai